{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:21:51Z","timestamp":1761578511585},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background: Data are sparse regarding the association between C-reactive protein (CRP) and percutaneous coronary intervention (PCI) in long-term prognosis. Previous studies have shown that PCI evokes an inflammatory response. We tested the hypothesis that the CRP response to PCI has a prognostic value.<\/jats:p>\n               <jats:p>Methods: We investigated 891 consecutive patients presenting with stable or unstable angina pectoris, with serum concentrations of cardiac troponin T \u22640.03 \u03bcg\/L, who were undergoing a variety of PCIs. Serum concentrations of CRP and cardiac troponin T were determined before and the day after PCI. The mean follow-up time after PCI was 2.6 years, and the endpoint was death or nonfatal myocardial infarction.<\/jats:p>\n               <jats:p>Results: Seventy-six patients reached the endpoint (4.6% death, 3.9% nonfatal myocardial infarction), whereas 21% developed myocardial infarction during the procedure. CRP increased more than 2-fold after the procedure. Patients in the third tertile of the CRP response to PCI had an increased risk for death or nonfatal myocardial infarction in multivariate analysis.<\/jats:p>\n               <jats:p>Conclusions: Increased serum CRP in response to PCI is an independent predictor of death or nonfatal myocardial infarction independent of myocardial injury during the procedure. CRP determinations might be of value in risk stratification after PCI.<\/jats:p>","DOI":"10.1373\/clinchem.2005.048082","type":"journal-article","created":{"date-parts":[[2005,9,15]],"date-time":"2005-09-15T20:24:11Z","timestamp":1126815851000},"page":"2124-2130","source":"Crossref","is-referenced-by-count":23,"title":["Response of Serum C-Reactive Protein to Percutaneous Coronary Intervention Has Prognostic Value"],"prefix":"10.1093","volume":"51","author":[{"given":"Nawsad","family":"Saleh","sequence":"first","affiliation":[{"name":"Departments of Cardiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertil","family":"Svane","sequence":"first","affiliation":[{"name":"Physiology and Thoracic Radiology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars-Olof","family":"Hansson","sequence":"first","affiliation":[{"name":"Department of Clinical Chemistry and Pharmacology, Uppsala University Hospital, Uppsala, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Jensen","sequence":"first","affiliation":[{"name":"Departments of Cardiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tage","family":"Nilsson","sequence":"first","affiliation":[{"name":"Physiology and Thoracic Radiology, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olle","family":"Danielsson","sequence":"first","affiliation":[{"name":"Clinical Chemistry, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Tornvall","sequence":"first","affiliation":[{"name":"Departments of Cardiology,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"2020022800525410100_R1","doi-asserted-by":"crossref","unstructured":"Buffon A, Liuzzo G, Biasucci L, Pasqualetti P, Ramazzotti V, Rebuzzi AG, et al. Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplasty. J Am Coll Cardiol1999;34:1512-1521.","DOI":"10.1016\/S0735-1097(99)00348-4"},{"key":"2020022800525410100_R2","doi-asserted-by":"crossref","unstructured":"Chew D, Bhatt D, Robbins M, Penn MS, Schneider JP, Laner MS, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation2001;104:992-997.","DOI":"10.1161\/hc3401.095074"},{"key":"2020022800525410100_R3","doi-asserted-by":"crossref","unstructured":"Heeschen C, Hamm CW, Bruemmer J, Simoons ML. The chimeric c7E3 antiplatelet therapy in unstable angina refractory to standard treatment (CAPTURE) investigators. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. J Am Coll Cardiol2000;35:1535-1542.","DOI":"10.1016\/S0735-1097(00)00581-7"},{"key":"2020022800525410100_R4","doi-asserted-by":"crossref","unstructured":"Rahel B, Visseren F, Suttorp M, Plokker TH, Kelder JC, de Jongh BM, et al. Preprocedural serum levels of acute-phase reactants and prognosis after percutaneous coronary intervention. Cardiovasc Res2003;60:136-140.","DOI":"10.1016\/S0008-6363(03)00355-9"},{"key":"2020022800525410100_R5","doi-asserted-by":"crossref","unstructured":"Walter D, Fichtlscherer S, Britten M, Rosin P, Auch-Schwelk W, Schachniger V, et al. Statin therapy, inflammation, and recurrent coronary events in patients following coronary stent implantation. J Am Coll Cardiol2001;38:2006-2012.","DOI":"10.1016\/S0735-1097(01)01662-X"},{"key":"2020022800525410100_R6","doi-asserted-by":"crossref","unstructured":"Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA, et al. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation. Am J Cardiol2000;85:92-95.","DOI":"10.1016\/S0002-9149(99)00612-8"},{"key":"2020022800525410100_R7","doi-asserted-by":"crossref","unstructured":"Winter R, Koch K, Van Straalen J, Heyde G, Bax M, Schotborgh CE, et al. C-Reactive protein and coronary events following percutaneous coronary angioplasty. Am J Med2003;115:85-90.","DOI":"10.1016\/S0002-9343(03)00238-9"},{"key":"2020022800525410100_R8","doi-asserted-by":"crossref","unstructured":"Winter R, Heyde G, Koch K, Fischer J, Van Straalen J, Bax M, et al. The prognostic value of pre-procedural plasma C-reactive protein in patients undergoing elective coronary angioplasty. Eur Heart J2002;23:960-966.","DOI":"10.1053\/euhj.2001.2988"},{"key":"2020022800525410100_R9","doi-asserted-by":"crossref","unstructured":"Lenderink T, Boersma E, Heeschen C, Vaharian A, de Boer MJ, Umans V, et al. Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PCI. Eur Heart J2003;24:77-85.","DOI":"10.1016\/S0195-668X(02)00322-6"},{"key":"2020022800525410100_R10","unstructured":"Zairis M, Ambrose J, Manousakis S, Stefanidis AS, Papadaki OA, Bilianou HI, et al. The impact of plasma levels of C-reactive protein, lipoprotein(a), and homocysteine on the long-term prognosis after successful coronary stenting. The global evaluation of new events and restenosis after stent implantation study. J Am Coll Cardiol2002;40:1375-1382."},{"key":"2020022800525410100_R11","doi-asserted-by":"crossref","unstructured":"Dibra A, Mehilli J, Braun S, Hadamitzky M, Baum H, Dirschinger J, et al. Association between C-reactive protein levels and subsequent cardiac events among patients with stable angina treated with coronary artery stenting. Am J Med2003;114:715-722.","DOI":"10.1016\/S0002-9343(03)00183-9"},{"key":"2020022800525410100_R12","doi-asserted-by":"crossref","unstructured":"Azar R, McKay R, Kiernan F, Seecharran B, Feng Y, Fram D, et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol1997;80:1476-1478.","DOI":"10.1016\/S0002-9149(97)00726-1"},{"key":"2020022800525410100_R13","doi-asserted-by":"crossref","unstructured":"Liu PY, Li YH, Tsai WC, Chao TH, Tsai LM, Wu HL, et al. Prognostic value and the changes of plasma levels of secretory type II phospholipidase A2 in patients with coronary artery disease undergoing percutaneous coronary intervention. Eur Heart J2003;24:1824-1832.","DOI":"10.1016\/j.ehj.2003.07.003"},{"key":"2020022800525410100_R14","doi-asserted-by":"crossref","unstructured":"Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol1998;82:515-518.","DOI":"10.1016\/S0002-9149(98)00370-1"},{"key":"2020022800525410100_R15","doi-asserted-by":"crossref","unstructured":"Davis G. Role of cardiac troponin testing in percutaneous transluminal coronary angioplasty. Scand J Clin Invest2003;63:167-174.","DOI":"10.1080\/00365510310001140"},{"key":"2020022800525410100_R16","doi-asserted-by":"crossref","unstructured":"Braunwald E. Unstable angina: a classification. Circulation1989;80:410-414.","DOI":"10.1161\/01.CIR.80.2.410"},{"key":"2020022800525410100_R17","doi-asserted-by":"crossref","unstructured":"Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. The fragmin during instability in coronary artery disease (FRISC) study group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med2000;343:1139-1147.","DOI":"10.1056\/NEJM200010193431602"},{"key":"2020022800525410100_R18","doi-asserted-by":"crossref","unstructured":"Morrow DA, Rifai N, Antman EM, Weiner DL, McCabe CH, Cannon CP, et al. C-Reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI-11A) substudy. J Am Coll Cardiol1998;31:1460-1465.","DOI":"10.1016\/S0735-1097(98)00136-3"},{"key":"2020022800525410100_R19","doi-asserted-by":"crossref","unstructured":"Carims JA, Theroux P, Lewis HD, Ezekowitz M, Meade TW. Antithrombotic agents in coronary artery disease. Chest2001;119(1 Suppl):228S-252S.","DOI":"10.1378\/chest.119.1_suppl.228S"},{"key":"2020022800525410100_R20","doi-asserted-by":"crossref","unstructured":"Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med1997;336:973-979.","DOI":"10.1056\/NEJM199704033361401"},{"key":"2020022800525410100_R21","doi-asserted-by":"crossref","unstructured":"Ikonomidis I, Adreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulus P. Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation1999;100:793-798.","DOI":"10.1161\/01.CIR.100.8.793"},{"key":"2020022800525410100_R22","doi-asserted-by":"crossref","unstructured":"Feng D, Tracy RP, Lipinska I, Murillo J, McKenna C, Tofler GH. Effect of short-term aspirin use on C-reactive protein. J Thromb Thrombolysis2000;9:37-41.","DOI":"10.1023\/A:1018644212794"},{"key":"2020022800525410100_R23","doi-asserted-by":"crossref","unstructured":"Feldman M, Jilal I, Devaraj S, Cryer B. Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations. A placebo-controlled study using a highly sensitive C-reactive protein assay. J Am Coll Cardiol2001;37:2036-2041.","DOI":"10.1016\/S0735-1097(01)01289-X"},{"key":"2020022800525410100_R24","doi-asserted-by":"crossref","unstructured":"Albert M, Danielson E, Rifai N, Ridker PM, . PRINCE Investigators. Effect of statin therapy on C-reactive protein levels. JAMA2001;286:64-70.","DOI":"10.1001\/jama.286.1.64"},{"key":"2020022800525410100_R25","doi-asserted-by":"crossref","unstructured":"Chan A, Bhatt D, Chew D, Quinn MJ, Molterno DJ, Topol EJ, et al. Early and sustained survival benefit associated with statin therapy at the time of percutaneous coronary intervention. Circulation2002;105:691-696.","DOI":"10.1161\/hc0602.103586"},{"key":"2020022800525410100_R26","doi-asserted-by":"crossref","unstructured":"Vivekananthan D, Bhatt D, Chew D, Zidar FJ, Chan AW, Molterno DJ, et al. Effect of clopidogrel pretreatment on periprocedural rise in C-reactive protein after percutaneous coronary intervention. Am J Cardiol2004;94:358-360.","DOI":"10.1016\/j.amjcard.2004.04.035"}],"container-title":["Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/51\/11\/2124\/32684332\/clinchem2124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/clinchem\/article-pdf\/51\/11\/2124\/32684332\/clinchem2124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T00:53:32Z","timestamp":1582851212000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/clinchem\/article\/51\/11\/2124\/5629698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":26,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,11,1]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1373\/clinchem.2005.048082","relation":{},"ISSN":["0009-9147","1530-8561"],"issn-type":[{"value":"0009-9147","type":"print"},{"value":"1530-8561","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,11,1]]},"published":{"date-parts":[[2005,11,1]]}}}